Literature DB >> 19618151

Predisposition to atherosclerosis and aortic aneurysms in mice deficient in kinin B1 receptor and apolipoprotein E.

Vanessa F Merino1, Mihail Todiras, Marcelo A Mori, Vicência M T Sales, Raphael G Fonseca, Vera Saul, Katja Tenner, Michael Bader, João B Pesquero.   

Abstract

Kinin B1 receptor is involved in chronic inflammation and expressed in human atherosclerotic lesions. However, its significance for lesion development is unknown. Therefore, we investigated the effect of kinin B1 receptor deletion on the development of atherosclerosis and aortic aneurysms in apolipoprotein E-deficient (ApoE(-/-)) mice. Mice deficient both in ApoE and in kinin B1 receptor (ApoE(-/-)-B(1)(-/-)) were generated and analyzed for their susceptibility to atherosclerosis and aneurysm development under cholesterol rich-diet (western diet) and angiotensin II infusion. Kinin B1 receptor messenger RNA (mRNA) expression was significantly increased in ApoE(-/-) mice after Western-type diet. Although no difference in serum cholesterol was found between ApoE(-/-)-B(1)(-/-) and ApoE(-/-) mice under Western-type diet, aortic lesion incidence was significantly higher in ApoE(-/-)-B(1)(-/-) after this treatment. In accordance, we observed increased endothelial dysfunction in these mice. The mRNA expression of cyclic guanosine monophosphate-dependent protein kinase I, CD-11, F4/80, macrophage colony-stimulating factor, and tumor necrosis factor-alpha were increased in the aorta of double-deficient mice following Western-type diet, whereas the levels of peroxisome proliferator-activated receptor gamma protein and the activity of matrix metalloproteinase-9 activity were decreased. In addition to the increased atherosclerotic lesions, the lack of kinin B(1) receptor also increased the incidence of abdominal aortic aneurysms after angiotensin II infusion. In conclusion, our results show that kinin B(1) receptor deficiency aggravates atherosclerosis and aortic aneurysms under cholesterolemic conditions, supporting an antiatherogenic role for the kinin B(1) receptor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19618151     DOI: 10.1007/s00109-009-0501-0

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  52 in total

Review 1.  The B1 receptors for kinins.

Authors:  F Marceau; J F Hess; D R Bachvarov
Journal:  Pharmacol Rev       Date:  1998-09       Impact factor: 25.468

2.  Modulation of kinin B1 receptor expression by endogenous angiotensin II in hypertensive rats.

Authors:  Liliam Fernandes; Graziela S Ceravolo; Zuleica B Fortes; Rita Tostes; Robson A S Santos; Jerusa A Santos; Marcelo A S Mori; João Bosco Pesquero; Maria Helena C de Carvalho
Journal:  Regul Pept       Date:  2006-07-05

3.  Molecular cloning of F4/80, a murine macrophage-restricted cell surface glycoprotein with homology to the G-protein-linked transmembrane 7 hormone receptor family.

Authors:  A J McKnight; A J Macfarlane; P Dri; L Turley; A C Willis; S Gordon
Journal:  J Biol Chem       Date:  1996-01-05       Impact factor: 5.157

Review 4.  The vascular biology of nitric oxide and its role in atherogenesis.

Authors:  D M Lloyd-Jones; K D Bloch
Journal:  Annu Rev Med       Date:  1996       Impact factor: 13.739

5.  Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study.

Authors:  Daniel G Hackam; Deva Thiruchelvam; Donald A Redelmeier
Journal:  Lancet       Date:  2006-08-19       Impact factor: 79.321

6.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

7.  B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects.

Authors:  L Morbidelli; A Parenti; L Giovannelli; H J Granger; F Ledda; M Ziche
Journal:  Br J Pharmacol       Date:  1998-07       Impact factor: 8.739

8.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.

Authors:  Y Nakashima; A S Plump; E W Raines; J L Breslow; R Ross
Journal:  Arterioscler Thromb       Date:  1994-01

9.  A study of the mediators involved in the protection induced by exogenous kinins in the isolated rat heart.

Authors:  Caroline Lagneux; Albert Adam; Daniel Lamontagne
Journal:  Int Immunopharmacol       Date:  2003-10       Impact factor: 4.932

Review 10.  Mouse models of atherosclerosis.

Authors:  J L Breslow
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728

View more
  11 in total

1.  Bradykinin in health and disease: proceedings of the Bradykinin Symposium 2012, Berlin 23-24 August 2012.

Authors:  Markus Magerl; Michael Bader; Anne Gompel; Kusumam Joseph; Allen P Kaplan; Georg Kojda; Thomas Renné; Markus Wirth; Marcus Maurer; Martin K Church
Journal:  Inflamm Res       Date:  2013-12-08       Impact factor: 4.575

2.  Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis.

Authors:  Hong Lu; Anju Balakrishnan; Deborah A Howatt; Congqing Wu; Richard Charnigo; Gene Liau; Lisa A Cassis; Alan Daugherty
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  Aneurysm formation and bradykinin.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2009-08-26       Impact factor: 4.599

Review 4.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

5.  Lack of kinin B₁ receptor potentiates leptin action in the liver.

Authors:  Raphael Gomes Fonseca; Vicencia Micheline Sales; Eduardo Ropelle; Carlos Castilho Barros; Lila Oyama; Silvia Saiuli Iuki Ihara; Mário Jose Abdalla Saad; Ronaldo Carvalho Araújo; João Bosco Pesquero
Journal:  J Mol Med (Berl)       Date:  2013-02-06       Impact factor: 4.599

6.  Protective role of AT(2) and B(1) receptors in kinin B(2)-receptor-knockout mice with myocardial infarction.

Authors:  Jiang Xu; Oscar A Carretero; Liping Zhu; Edward G Shesely; Nour-Eddine Rhaleb; Xiangguo Dai; Luchen Wang; James J Yang; Xiao-Ping Yang
Journal:  Clin Sci (Lond)       Date:  2013-01       Impact factor: 6.124

7.  Kinin B1 receptor in adipocytes regulates glucose tolerance and predisposition to obesity.

Authors:  Marcelo A Mori; Vicência Micheline Sales; Fabiana Louise Motta; Raphael Gomes Fonseca; Natalia Alenina; Dioze Guadagnini; Ines Schadock; Elton Dias Silva; Hugo A M Torres; Edson Lucas dos Santos; Charlles Heldan Castro; Vânia D'Almeida; Sandra Andreotti; Amanda Baron Campaña; Rogério A L Sertié; Mario J A Saad; Fabio Bessa Lima; Michael Bader; João Bosco Pesquero
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

8.  Individualised therapy of angiotensin converting enzyme (ACE) inhibitors in stable coronary artery disease: overview of the primary results of the PERindopril GENEtic association (PERGENE) study.

Authors:  J J Brugts; M P M de Maat; A H J Danser; E Boersma; M L Simoons
Journal:  Neth Heart J       Date:  2012-01       Impact factor: 2.380

9.  Vascular Kinin B1 and B2 Receptors Determine Endothelial Dysfunction through Neuronal Nitric Oxide Synthase.

Authors:  Thássio R R Mesquita; Gianne P Campos-Mota; Virgínia S Lemos; Jader S Cruz; Itamar C G de Jesus; Enilton A Camargo; Jorge L Pesquero; João B Pesquero; Luciano Dos Santos A Capettini; Sandra Lauton-Santos
Journal:  Front Physiol       Date:  2017-04-28       Impact factor: 4.566

10.  Associations Between Plasma Kinin B1 Receptor Levels and the Presence and Severity of Coronary Artery Disease.

Authors:  Yoshimi Kishimoto; Masayuki Aoyama; Emi Saita; Yukinori Ikegami; Reiko Ohmori; Kazuo Kondo; Yukihiko Momiyama
Journal:  J Atheroscler Thromb       Date:  2020-10-30       Impact factor: 4.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.